4.8 TA-TMA Management, Complement-Directed Therapy & Other Endothelial Syndromes

1. Therapeutic Management and Complement-Directed Safety

Stabilize, Confirm, and Treat Drivers

• Trend CBC, smear, LDH, haptoglobin, bilirubin, creatinine, urine protein, blood pressure, neurologic findings, and organ function; evaluate infection, GVHD, drugs, relapse, DIC, TTP, and other hemolysis.
• Control severe hypertension and support renal, neurologic, respiratory, transfusion, and infectious needs. Avoid nephrotoxins when alternatives exist.
• Review calcineurin/mTOR exposure and levels with the transplant team. A hold, dose change, switch, or continuation is individualized because abrupt withdrawal can worsen GVHD; “stop every CNI” is not a universal rule.
• Plasma exchange is not standard TA-TMA monotherapy unless another indication such as TTP is suspected.

Complement-Directed Therapy

Eculizumab blocks cleavage of C5 and terminal membrane-attack-complex formation. Its use for TA-TMA is off-label; selection, dosing, pharmacodynamic monitoring, response criteria, and duration follow specialist and center protocols. Other complement-directed approaches may be available through disease-specific programs or trials. Nurses verify the actual order and monitoring plan rather than applying a fixed transplant dose from memory.

Meningococcal Risk With C5 Inhibition

Current eculizumab labeling requires enrollment in the product REMS and meningococcal risk counseling. Give MenACWY and MenB vaccines according to current ACIP recommendations, ideally at least two weeks before the first dose when delaying therapy is safe. If urgent treatment begins before vaccination is complete or up to date, provide the antibacterial prophylaxis ordered under the label and clinical plan. Vaccination does not eliminate risk, and some experts consider prophylaxis for the treatment duration in selected patients, but the label does not mandate one universal antibiotic throughout therapy plus 60 days.

Teach the patient to carry the safety information and seek immediate evaluation for fever, severe headache, stiff neck, photophobia, confusion, myalgia with flu-like illness, or petechial/purpuric rash. Suspected meningococcal disease is an emergency even in a vaccinated patient.

2. Other Acute Post-Transplant Endothelial Syndromes

In addition to TA-TMA and SOS/VOD, nurses must recognize two additional acute post-transplant endothelial syndromes: Capillary Leak Syndrome and Engraftment Syndrome.

1. Capillary Leak Syndrome (CLS)

• Timing & Mechanism: Occurs early during conditioning or pre-engraftment. Cytokines, infection, drugs, and conditioning injury can disrupt the endothelial barrier.
• Clinical Manifestations: Weight gain, edema, hypoalbuminemia, hypotension or intravascular depletion, and organ dysfunction require urgent differential assessment.
• Management: Treat the driver and support oxygenation/hemodynamics while balancing intravascular volume and edema. Albumin, diuresis, or corticosteroids are indication- and protocol-specific, not a universal bundle.

2. Engraftment Syndrome (ES) / Pre-Engraftment Syndrome

Engraftment syndrome is a noninfectious inflammatory syndrome temporally associated with neutrophil recovery, often featuring otherwise unexplained fever, rash, pulmonary edema/hypoxemia, weight gain, or organ dysfunction. Criteria differ, and infection, fluid overload, drug reaction, and GVHD must be evaluated. The team may use systemic corticosteroids for clinically significant disease while continuing supportive care and infection assessment.

Comparative Overview of Acute Post-HSCT Endothelial Syndromes

3. Diffuse Alveolar Hemorrhage and Idiopathic Pneumonia Syndrome

TA-TMA can involve the lung, but two additional non-infectious pulmonary syndromes belong in the same differential and are distinguished by how they are diagnosed rather than by how they look at the bedside. Both present as hypoxia with diffuse infiltrates in a patient who is often near neutrophil recovery, and both are diagnoses of exclusion that require an infectious workup first.

Diffuse alveolar hemorrhage (DAH) is bleeding into the alveolar space from injured pulmonary microvasculature. It presents with progressive dyspnea, hypoxia, and diffuse infiltrates, and notably hemoptysis is frequently absent, which is why it is missed. The diagnosis is made at bronchoscopy: serial bronchoalveolar lavage aliquots become progressively bloodier rather than clearing, and hemosiderin-laden macrophages support the finding. A falling hemoglobin without an external bleeding source in a hypoxic patient should prompt the question directly. Management is supportive with oxygenation and ventilatory support, correction of coagulopathy and thrombocytopenia, and specialist decisions about systemic corticosteroids.

Idiopathic pneumonia syndrome (IPS) is widespread alveolar injury with no identified infectious cause after a thorough evaluation including bronchoalveolar lavage. It presents with hypoxia, diffuse infiltrates, and restrictive physiology. Because the definition is exclusionary, the nursing contribution is ensuring the infectious workup is genuinely complete and that specimens were obtained before empiric therapy narrowed the picture.

4. What the Nurse Contributes to These Diagnoses

Every syndrome in this section is diagnosed from a trajectory rather than a single value, which makes serial nursing documentation the raw material for the diagnosis. Daily weights taken on the same scale at the same time, accurate intake and output, abdominal girth where ordered, oxygen requirement expressed as the delivery device rather than a saturation number alone, and blood pressure trends recorded against the patient's own baseline are the data the team uses to separate these overlapping syndromes.

Escalate the rate of change, not just the absolute value. A creatinine that has doubled inside forty-eight hours, an oxygen requirement that has climbed from room air to six liters over one shift, or a two-kilogram overnight weight gain each carry more diagnostic weight than any of those numbers do in isolation.